1.Construction and acceptance standards of smart traditional Chinese medicine pharmacy
Tao WANG ; Tangyi PENG ; Xu WANG ; Xiang CHEN ; Xueqiong LIU
China Pharmacy 2024;35(17):2077-2081
OBJECTIVE To develop the norms for the construction and acceptance of smart traditional Chinese medicine (TCM) pharmacy, and to provide guidance for the construction and acceptance of smart TCM pharmacy in medical institutions at all levels. METHODS In April 2023, a drafting group was established to publicly solicit opinions through websites, meetings, and other means. Research was conducted through methods such as demand research, field visits, literature review, and expert interviews. Combined with the experience of TCM pharmacy construction in various medical institutions, the main content and requirements of smart TCM pharmacy construction, as well as the preparation of various acceptance indicators, were completed in December 2023. RESULTS The construction and acceptance standards for smart TCM pharmacy in Anhui Province were completed. On February 11, 2024, the Anhui Provincial Administration for Market Regulation approved the release and implementation of the local standards for the Construction and Acceptance of Smart TCM Pharmacy (DB34/T4700-2024). CONCLUSIONS The formulated standards are applicable to the construction and acceptance of smart TCM pharmacy in various medical institutions, provide a basis for medical institutions to carry out standardized construction and acceptance of smart TCM pharmacy, thus promoting the service capabilities of TCM pharmacy of medical institutions in Anhui Province.
2.A pan-cancer analysis of TTC9A expression level and its correlation with prognosis and immune microenvironment
Yina YAO ; Jia LIU ; Xiangjun ZHOU ; Zeyu LIU ; Shizhen QIU ; Yingzheng HE ; Xueqiong ZHOU
Journal of Southern Medical University 2024;44(1):70-82
Objective To investigate the expression level of tetratricopeptide repeat protein 9A in tumors and its association with the patients'prognosis and immune infiltration.Methods TTC9A expression in different tumor tissues and its association with prognosis,DNA methylation,tumor mutation burden(TMB),and microsatellite instability(MSI)were analyzed based on data from TCGA and GTEx.TIMER and xCell were used to analyze the relationship between TTC9A expression and immune infiltration.Western blotting and RT-qPCR were used to detect the expression of TTC9A in 4 types of cancer cell lines.Results TTC9A expressions were significantly increased in many tumors and down-regulated in a few cancer types(P<0.05).Western blotting and RT-qPCR showed that TTC9A expressions were elevated in lung,colon and liver cancer cells but decreased in bladder cancer cells.In head and neck squamous cell carcinoma,renal clear cell carcinoma,renal papillary cell carcinoma,low-grade glioma,malignant mesothelioma,and endometrial carcinoma tumors,a high expression of TTC9A was strongly correlated with better overall survival(OS),disease-specific survival(DSS),and progression-free interval(PFI)(P<0.05),but was correlated with worse OS,DSS,and PFI in lung adenocarcinoma,pancreatic adenocarcinoma,adrenal carcinoma,and rectal adenocarcinoma(P<0.05).TTC9A hypermethylation was associated with a more favorable prognosis of glioblastoma multiforme,low-grade glioma,uveal melanoma,and ovarian plasmacytoid cystadenocarcinoma(P<0.05)but with poor prognosis of squamous cell carcinoma of the uterine cervix and intracervical adenocarcinoma,squamous cell carcinoma of head and neck,squamous cell carcinoma of the lungs,adrenal carcinoma,and endometrial carcinoma(P<0.05).In most of the cancer types,TTC9A was significantly correlated with the level of immune cell infiltration(P<0.05).Conclusion TTC9A can be used as a prognostic marker for a variety of cancers and is strongly associated with TBM,MSI and immune cell infiltration.
3.A pan-cancer analysis of TTC9A expression level and its correlation with prognosis and immune microenvironment
Yina YAO ; Jia LIU ; Xiangjun ZHOU ; Zeyu LIU ; Shizhen QIU ; Yingzheng HE ; Xueqiong ZHOU
Journal of Southern Medical University 2024;44(1):70-82
Objective To investigate the expression level of tetratricopeptide repeat protein 9A in tumors and its association with the patients'prognosis and immune infiltration.Methods TTC9A expression in different tumor tissues and its association with prognosis,DNA methylation,tumor mutation burden(TMB),and microsatellite instability(MSI)were analyzed based on data from TCGA and GTEx.TIMER and xCell were used to analyze the relationship between TTC9A expression and immune infiltration.Western blotting and RT-qPCR were used to detect the expression of TTC9A in 4 types of cancer cell lines.Results TTC9A expressions were significantly increased in many tumors and down-regulated in a few cancer types(P<0.05).Western blotting and RT-qPCR showed that TTC9A expressions were elevated in lung,colon and liver cancer cells but decreased in bladder cancer cells.In head and neck squamous cell carcinoma,renal clear cell carcinoma,renal papillary cell carcinoma,low-grade glioma,malignant mesothelioma,and endometrial carcinoma tumors,a high expression of TTC9A was strongly correlated with better overall survival(OS),disease-specific survival(DSS),and progression-free interval(PFI)(P<0.05),but was correlated with worse OS,DSS,and PFI in lung adenocarcinoma,pancreatic adenocarcinoma,adrenal carcinoma,and rectal adenocarcinoma(P<0.05).TTC9A hypermethylation was associated with a more favorable prognosis of glioblastoma multiforme,low-grade glioma,uveal melanoma,and ovarian plasmacytoid cystadenocarcinoma(P<0.05)but with poor prognosis of squamous cell carcinoma of the uterine cervix and intracervical adenocarcinoma,squamous cell carcinoma of head and neck,squamous cell carcinoma of the lungs,adrenal carcinoma,and endometrial carcinoma(P<0.05).In most of the cancer types,TTC9A was significantly correlated with the level of immune cell infiltration(P<0.05).Conclusion TTC9A can be used as a prognostic marker for a variety of cancers and is strongly associated with TBM,MSI and immune cell infiltration.
4.Barriers to active aging of elderly people in western China: a qualitative study
Qingquan LIU ; Li LIU ; Jianzheng CAI ; Xueqiong XU ; Xiuying HU
Chinese Journal of Modern Nursing 2023;29(31):4227-4231
Objective:To understand the barriers to active aging among elderly people in western China and provide reference for formulating targeted interventions.Methods:This study was a qualitative study. From September to December 2022, purposive sampling was used to select 15 elderly people from Chengdu as the research subject for semi-structured interviews. Data analysis was conducted using the Colizzi 7-step analysis method.Results:The barriers to the active aging of elderly people in western China included three themes and six sub-themes, namely low levels of health self-management (low level of health awareness, lack of healthy lifestyle), hindered social participation (low personal willingness to participate in society, weak social participation support system), and weak social security system (heavy burden of medical care, poor accessibility of multi-channel elderly care services) .Conclusions:There are many barriers in the active aging process of elderly people in the western region of China. While improving the elderly care system and expanding service supply, society should fully consider the needs of the elderly, exert their subjective initiative, create an active aging atmosphere, and promote the smooth realization of active aging for the elderly in western China.
5.Role of T cell immunoglobulin domain and mucin domain-3 and galectin-9 pathway in maintaining pregnancy immune tolerance
Yan YANG ; Min JIANG ; Xueqiong LIU ; Dan LU
Chinese Journal of Perinatal Medicine 2020;23(8):561-564
Galectin-9 (Gal-9) is a member of the lectin family expressed in NK cells, dendritic cells, macrophages, T helper cells, regulatory T cells, etc. T cell immunoglobulin domain and mucin domain-3 (Tim-3) interact with ligand Gal-9 mediating different immune regulatory effects in different immune cells. This Tim-3/Gal-9 pathway is associated with various conditions, such as autoimmune diseases, tumors, virus infections, and pregnancy-related diseases. This paper reviews the role of the Tim-3/Gal-9 pathway in maintaining immune tolerance in pregnancy by regulating innate and adaptive immune responses and its potential as a new target for immunotherapy in pregnancy-related diseases.
6.Current situation analysis of ethical review and implementation of animal welfare about animal experiments in hospitals
Hailing LIU ; Miaomiao YE ; Yuan CHEN ; Xueqiong ZHU
Chinese Journal of Medical Science Research Management 2020;33(1):64-69
Objective This paper analyzes the situation and problems of animal experiments in hospitals,which including the ethical review,regulatory compliance of animal welfare and animal experimental use,proposing possible measurements for reference.Methods We retrospectively searched Wanfang database,used specific search terms and classification methods to analyze the current situation and problems of ethical review in conducting animal experiment in hospitals.Results In all papers,71 mentioned that the experiment got ethical review approval,accounting for 9.2%;411 mentioned about content of animal welfare,accounting for 53.3%;and 75 referred to the laws and regulations of animal experiments,taking up 9.7%.70 (9.6%) papers focused on both feeding conditions and euthanasia.However,339 (46.4%) papers did not mention any of them.In reference to the approval of animal welfarecommittee,there was a significant difference between funded papers and non-funded papers.In animal welfare,there was no significant difference between papers with funds or not.In the laws and regulations of animal experiment,there were significant differences between state-funded papers and non-state-funded papers.Conclusions So far,when carrying out animal experiments in hospitals,little attention has been paid to the ethical review,so was to the regulatory compliance of animal welfare and animal experimental use.Researchers should constantly strengthen their awareness of animal protection,make sure compliance with the welfare principles of experimental animals,animal protection laws and regulations,and further standardize animal research.
7.Current situation analysis and countermeasures of informed consent and ethical review about clinical trial involving human subject in hospitals
Miaomiao YE ; Hailing LIU ; Yuan CHEN ; Xueqiong ZHU
Chinese Journal of Medical Science Research Management 2019;32(3):169-175
Objective To explore the current situation of informed consent and ethical review of clinical trial involving human subject in hospitals,and provide related countermeasures.Methods This study searches the website (http://med.wanfangdata.com.cn/Paper),selects "hospital" as the search term,and uses "all fields" as the search criteria.Collected papers were about clinical trial involving human subject that published during Jan.2018 to Feb.2018 in internal medicine,surgery,obstetrics and gynecology,pediatrics.The current situation of informed consent and ethical review of these papers were analyzed from various aspects,including the hospital grades,medical institutions types,clinical research methods,study types,fund projects,periodical category.Results (1) Among 1964 papers,only 538 (27.4%) papers obtained informed consent of subjects and the ethical review approval.(2) There are no significant differences between different hospital grades,and different medical institutions about informed consent and ethical review.(3) Experimental studies focus more on informed consent and ethical review than observational studies.(4) Drug clinical trials focuses more on informed consent and ethical review than non-drug related clinical study.(5) Fund projects focus more on informed consent and ethical review than non-fund pro jects.(6) Papers published in core periodical focus more on informed consent and ethical review than papers published in other periodical.Conclusions Currently,conducting clinical trial involving human subject still does not pay enough attention to the informed consent of subjects and ethical review,more countermeasures are needed to change the current situation and to standardize human clinical trials.
8.A new method for screening latent tuberculosis infection in Beijing army recruits
Yunlin ZHANG ; Xuejuan BAI ; Yan LIANG ; Jingyu GUO ; Guoying WANG ; Liu HE ; Shumei YANG ; Xueqiong WU
Military Medical Sciences 2017;41(6):462-465
Objective To investigate the Mycobacterium tuberculosis infections in 2014 among Beijing army recruits, and evaluate a new method for screening latent tuberculosis infections.Methods A total of 194 army recruits were subjected to chest X-ray examination purified protein derivative(PPD) skin test, antibody detection, and interferon gamma release assay(IGRA) by ELISA combined with recombinant protein CFP10-ESAT6 and latent infection protein Rv2628.Results The positive rates of PPD skin test and antibody test were 49.7% and 15.5%, respectively.The latent infection rate of IGRA test was 22.2% in 194 cases after CFP10-ESAT6 stimulation.After stimulation of latent tuberculosis infection(LTBI) with Rv2628, IFN-γ level was significantly higher than that in healthy control group (P<0.05).The weak positive group of TST (5 mm≤diameter<15 mm) had a significantly higher level of IFN-γ than the strong positive group(diameter≥15 mm)(P<0.05),but after stimulation with CFP10-ESAT6,IFN-γ levels were not significantly different between the two groups(P>0.05).There was no significant difference between antibody negative and positive groups after stimulation by CFP10-ESAT6 and Rv2628 (P>0.05).The area under the ROC curve of Rv2628 diagnosis of tuberculosis infection was 0.84.When Youden index was 0.621,the specificity was 94.7% and sensitivity was 67.4%.ConclusionCombined detection of antigens Rv2628 and CFP10-ESAT6 specific IFN-γ values can be potentially used for differential diagnosis of active or latent tuberculosis infections.
9.Effect of Wenjingtongluo prescription combined with acupuncture and moxibustion on ESR, Fib and hemorheology in patients with cervical spondylosis
Ning JIA ; Jiaen YANG ; Guangyao ZHU ; Guangjin ZHOU ; Xueqiong LIANG ; Shanshan LIU
Chinese Journal of Biochemical Pharmaceutics 2016;36(4):118-120
Objective To investigate effect of Wenjingtongluo prescription combined with acupuncture and moxibustion on ESR, Fib and hemorheology in patients with cervical spondylosis.Methods 110 cases of cervical spondylosis were divided into two groups, 55 cases in each group.The control group was treated with acupuncture and moxibustion.Experimental group on the basis of acupuncture treatment, were given Wenjingtongluo prescription.The PRI index, VAS score and blood rheology of the two groups were compared.Results The total effective rate of the experimental group was significantly higher than that of the control group (92.73% vs 76.36%) .There was a significant difference (χ2 =5.636, P <0.05) .After treatment, the two groups of PRI index ( emotional score, sensory score, total score ) , VAS score were significantly reduced ( P <0.05 ) .After treatment, the PRI index ( sensory score, total score) and VAS score of the experimental group were significantly lower than those of the control group after treatment.The difference was statistically significant(P<0.05).After treatment, two groups of ESR, Fib, PCV, whole blood viscosity, whole blood viscosity decreased significantly( P<0.05).The experimental group after treatment, ESR, Fib, PCV, whole blood viscosity, whole blood viscosity was significantly lower than the control group after treatment.The difference was statistically significant(P<0.05).Conclusion Wenjingtongluo prescription combined with acupuncture can significantly improve the clinical symptoms, reduce the pain of patients and improve the level of blood rheology.
10.Identification of Xanthii Fructus and Its Adulterants Based on ITS2 Sequence
Jun WANG ; Xia LIU ; Yaqin ZHANG ; Ming SONG ; Yunhan LIN ; Xiaoxi MA ; Wei SUN ; Li XIANG ; Zhigang HU ; Lan WU ; Xueqiong ZHANG ; Weiyi HU
World Science and Technology-Modernization of Traditional Chinese Medicine 2014;(2):329-334
Objective: To identify Xanthii Fructus and secure its quality and safety in medication. Methods: Total ge-nomic DNA was extracted from Xanthii Fructus and its adulterants. ITS2 sequences were amplified, and purified PCR products were sequenced. Sequence assembly and consensus sequence generation were performed using the CodonCode Aligner V 4.2. The Kimura 2-Parameter (K2P) distances were calculated using MEGA 5.0. The neigh-bor-joining (NJ) phylogenetic trees were constructed. Results: The intraspecific genetic distances of Xanthii Fructus were 0. The interspecific genetic distances between Xanthii Fructus and its adulterants were ranged from 0.009 to 0.542. The NJ tree showed that Xanthii Fructus could differ from its adulterants obviously. Conclusion: ITS2 can be used to identify Xanthii Fructus from its adulterants effectively, and our study further confirmed the effectiveness of ITS2 to identify traditional Chinese medicinal materials.

Result Analysis
Print
Save
E-mail